Life Sciences / GMP Clinical Trial Materials / Solubility & Bioavailability Enhancement

Solubility & Bioavailability Enhancement

Pace® offers small scale feasibility and current Good Manufacturing Practices (cGMP) pilot scale processes for bioavailability enhancement of orally administered small molecules.

Leverage our commercially proven approaches to boosting bioavailability for poorly water-soluble drugs through production of amorphous solid dispersions and nanoparticle dispersions. Our team can rapidly assess the feasibility of multiple bioavailability enhancement techniques when traditional approaches are not sufficient.

Connect with Pace® to learn how we can help enhance your small molecule.

Benefits Of Amorphous & Nanoparticle Dispersions

  • Drastically increases dissolution rate and apparent drug solubility.
  • Capable of providing multi-fold increases in drug bioavailability.
  • Feasibility can be performed at gram scale making it suitable for early development.
  • Proven commercial track record.

Development Of Amorphous & Nanoparticle Dispersions

  • Lab and pilot scale capabilities for R&D and GMP processing.
  • Capabilities to process solid dispersion intermediates into finished product.
  • Biorelevant dissolution studies of solid dispersions.
  • Solid state characterization of solid dispersions.
  • Physical stability studies.
Technique
Equipment
Model
Type
Spray Drying
Spray Dryer
Mobile Minor Closed Cycle
GEA
Spray Dryer
B-290/295/296
Buchi
Hot Melt Extrusion
Hot Melt Extruder
ZSE-18HP-e
Leistritz
Hot Melt Extruder
ZSE-16 attachment
Leistritz
Loss-in-weight powder feeders (x2)
K-CL-24-KT20
K-Tron
Micro Liquid Additive Injection System
Optos-Series
Eldex
Side Stuffer
LSB-17
Leistritz
Chill Roll Cooler-Conveyor
AL-0810
Leistritz
Air-Quench Cooling Take-off Unit
AL-06
Leistritz
Dual Drive Stainless Steel Micro Pelletizer
Model 25
Leistritz
Nanoparticles
High Efficiency Bead Mill
Dyno(R)-Mill ECM-AP 05
WAB US Corp.